Clinical Trials Directory

Trials / Sponsors / Sophiris Bio Corp

Sophiris Bio Corp

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedIntraprostatic PRX302 Injection to Treat Localised Prostate Cancer
Prostate Cancer
Phase 22017-06-07
CompletedEvaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate C
Prostate Cancer
Phase 22015-07-01
CompletedRandomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 f
Benign Prostatic Hyperplasia
Phase 32013-10-01
CompletedStudy of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)
Benign Prostatic Hyperplasia
Phase 1 / Phase 22011-09-01
CompletedTransperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperpl
Benign Prostatic Hyperplasia
Phase 22009-01-01
WithdrawnConvection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Gliobla
Glioblastoma Multiforme
Phase 22009-01-01
CompletedAn Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate C
Locally Recurrent Prostate Cancer
Phase 22008-02-01
CompletedPSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer
Prostate Cancer
Phase 12006-03-01